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The global COVID-19 pandemic first appeared in Wuhan, China in late 2019 (World Health 
Organisation, 2020) and since then has caused unprecedented economic and social 
disruption as well as presenting a major challenge to public health (World Health 
Organisation, 2020).  
 
On the 8th December 2020 the first person in the UK received a Coronavirus vaccination, 
since then efforts to roll out the vaccine have been encouraging. As of March 15th, 2021, 24, 
453,221 individuals have received their first vaccine dose, while 1,610,280 have received a 
second dose. In Northern Ireland 629, 461 received a first dose and 54,636 received a 
second dose (Public Health England 2021).  
 
Despite the mass progress in the public health distribution of vaccinations, there are 
individuals who will perceive vaccination as unsafe and/or unnecessary. Vaccine hesitancy 
also known as anti-vaccination or anti-vax is when there is a delay in acceptance or refusal 
of a vaccine by an individual despite their availability to the public.   
 
The overall aims of the survey were to assess COVID-19 vaccine uptake and hesitancy in 
Northern Ireland and the Republic of Ireland, and to offer evidence-based guidance on 




• 66.7% of the sample intended to get a vaccination as soon as possible 
• 27.15% reported that they will get their vaccine when others get theirs and when it is 
clear there are no side effects. 
• 6.15% of the sample have no intention of getting a vaccine 
• There is a high mean intention (M=6.12) to get a COVID-19 vaccine (TPB) 
• There is a high level of confidence to get a COVID-19 vaccine (VCS) 
• There was low vaccine hesitancy (score (M=2.49) as measured by the VAX scale 
• There is uncertainty and mistrust of side effects for children, this may because there 
is no vaccine currently available for children, or parents being apprehensive about 
children receiving a safe vaccine in the future. 
 
The report includes a detailed breakdown of the survey questions, and recommendations. A 
summary powerpoint presentation of the report is also available. Follow up interviews are 
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The global COVID-19 pandemic first appeared in Wuhan, China in late 2019 (World Health 
Organisation, 2020) and since then has caused unprecedented economic and social disruption 
as well as presenting a major challenge to public health (World Health Organisation, 2020). As of 
March 12th, 2021, the disease has infected more than 118, 707, 983 people with 2, 631,385 
deaths worldwide. In Europe there has been 38, 947, 362 confirmed cases and 881,973 reported 
deaths (Dong & Gardner, 2021).  In the United Kingdom 4.26 million (England=3.73m; Scotland 
=210K; Wales = 207K; Northern Ireland =115K) cases of coronavirus and 126,000 (England= 
111K; Scotland =7,510; Wales = 5,454; Northern Ireland =2099) deaths are reported (Dong & 
Gardner, 2021), while in the Republic of Ireland 227K confirmed cases and 4,534 deaths were 
reported.  
 
Due to the initial lack of a vaccine governments worldwide introduced extreme lockdown and 
quarantine measures, social distancing, and restrictions in face to face education, workplace and 
commercially available shopping services all to protect the vulnerable and restrict demand on 
health care services. The impact on these lockdowns has seen an increase in unemployment 
rates, employees being furloughed, business disruption and school and university closure, with 
children being home schooled by parents/family, and university teaching being delivered online.  
 
COVID-19 Vaccine  
The development of an effective vaccine against coronavirus to avoid further human and social, 
and economic loss was required.  Vaccinations are an important method of public health disease 
prevention involving the administration of a microorganism in a live, killed or weakened state to 
stimulate immunity against disease (Centers for Disease Control and Prevention, 2018).The 
development of a vaccine was expedited by the United Kingdom (UK) Government Vaccine 
Taskforce (VTF) with several Covid-19 vaccine trials undertaken to identify which vaccines are 
both safe and effective, so that vaccination programmes can start as early as possible.  
On the 8th December 2020 the first person in the UK received a Coronavirus vaccination, since 
then efforts to roll out the vaccine have been encouraging. As of March 15th, 2021, 24, 453,221 
individuals have received their first vaccine dose, while 1,610,280 have received a second dose. 
In Northern Ireland 629, 461 received a first dose and 54,636 received a second dose of a vaccine 
(Public Health England 2021). Vaccine distribution is different between NI and Republic of Ireland. 
In the Republic of Ireland as of the 13th March 2021 451,589 individuals received a first vaccine 
dose while 164,345 had received a second dose (Government of Ireland, Health Executive 
Service, 2021). 
 
Encouragingly, 79% of 140,000 people surveyed in 140 countries indicated vaccines are safe and 
73% reported that they trusted a doctor or nurse more than any other source of health advice 
(The Wellcome Trust, 2019).  From the same survey of UK respondents (n=1000) 75% felt that 
vaccines were safe, and 95% of those with children have had their children vaccinated.  These 
figures are similar to those in the Republic of Ireland, where 73% of participants felt vaccines were 




Despite the mass progress in the public health distribution of the vaccinations, there are 
individuals who will perceive vaccination as unsafe and/or unnecessary (Dubé et al., 2013). 
Vaccine hesitancy (also known as anti-vaccination or anti-vax) is defined as the delay in 
acceptance or refusal of a vaccine despite their availability to the public (Butler & MacDonald, 
2018).  Pre COVID-19, vaccine hesitancy was listed as one of the top ten threats to global public 
health, as a result it was recommended that countries incorporate plans to measure and address 
vaccine hesitancy into their public health programmes (WHO, 2018).  
 
There are several explanations for vaccine hesitancy, some of which are medical and ethical 
concerns that have been in existence since the emergence of vaccines in the 1700’s (Schwartz, 
2012, Hussain et al., 2018). Recently, in 2019 the WHO identified complacency and 
inconvenience in accessing vaccines as some of the key reasons underlying vaccine hesitancy. 
Several psychological have also been proposed. These include: confidence to get a vaccine, 
altruistic beliefs about who is being protected; personality traits such as neuroticism and 
conscientiousness, conspiracy, religious beliefs, paranoid beliefs, mistrust of authority and the 
attitudes and behaviour of others (family, friends and health professionals) towards vaccines 
(Murphy et al, 2021).  
 
Factors found to increase hesitancy include: forgetting to register for a vaccine, location of the 
vaccine centre, misinformation, lack of disabled access, previously declining a vaccine, a 
preference for natural immunity and worries about unforeseen future side effects of receiving a 
vaccine. A list of factors are shown in Figure 1. 
 





Vaccine Hesitancy and children 
Vaccine hesitancy does not appear to be the same across the population. Over a decade ago 
hesitancy was reported to be on the rise amongst parents (Gowda & Dempsey, 2013) with 
concerns and a distrust about the potential side effects vaccines can have on children in the 
immediate and short-term. This distrust in vaccines for children may be in part due to a discredited 
case series in the Lancet (1997) that suggested measles, mumps and rubella (MMR) vaccine 
predisposed children to behavioural regression and pervasive developmental disorder (Rao & 
Andrade, 2011). The Lancet publication led to a plethora of studies, refuting the link between 
autism and vaccination (Taylor et al., 1999, Dales et al., 2001), although damage to parental 
confidence, and public opinion on vaccine certainty for children may have already occurred, 
evident in a measles outbreaks in the UK, USA and Canada in 2008/2009 due in part to parental 
hesitancy and children not being vaccinated (Eggertson, 2010). This finding would then suggest 
that public health authorities and effective communication to the public plays an important role in 
ensuring scientific guidance and information on vaccines is not misleading, and that anti-
immunisation rhetoric or fashionable conspiracy theories are downplayed. According to Keelan et 
al., (2007) online anti-immunisation videos have gained a large viewing by the public, and social 
media support. The effects of anti-vaccine media has been shown to influence public attitudes, 
beliefs, and perceived social norms as predictors of vaccine uptake (Britt & Englebert, 2018).  
Vaccine Hesitancy and COVID-19. 
 
Unfortunately, Covid-19 vaccine hesitancy research is limited in Northern Ireland and the Republic 
of Ireland making public health decisions regarding communicating effectively with the public 
more difficult. A study by Murphy et al (2021) examined the factors that influence vaccine 
hesitancy and uptake, they showed 35%  of those in Republic of Ireland and 48.9% in Northern 
Ireland (Murphy, et al., 2021) were hesitant. The survey was conducted during the first COVID-
19 national lockdown when a vaccine hadn’t been developed, hence views of the public on a 
vaccine could be very different, furthermore a small sample size from NI  (n=46) took part. To 
date, no studies have included a psychological behaviour change theory to predict COVID-19 
vaccine uptake in NI that would provide a further level of detail when advising the public health 
authorities.  
 
Psychological Behaviour Change  
Several psychological behaviour change theories have their origins in social, and cognitive 
sciences, and explain, how and why individuals engage in intentional health behaviours (Craig et 
al., 2013; Hagger & Chatzisarantis, 2014). By integrating psychological behaviour change theory 
such as the Theory of Planned Behaviour into survey design of health intention and behaviours, 
the psychological mechanisms of behaviour change can be better understood, then 
operationalized when making recommendations on public health messaging (National Institute 
for Health & Care Excellence, 2018).  
 
The Theory of Planned Behaviour (TPB, Ajzen, 1991) states that an individual’s attitudes/beliefs, 
subjective norms and perceived behavioural control predict intentions and subsequent 
behaviours.  The TPB, has been used previously to explain vaccine uptake, although the current 
study is the first where TPB will be applied to COVID-19 vaccine uptake and hesitancy in NI. As 
already described in the introduction there are many factors that can predict hesitancy and uptake, 
so in addition to TPB factors, other factors will be included as predictors. These other factors 
include: Participant Demographics (Age, Gender, Employment, Educational Level, Ethnicity), 
Previous Experience of COVID-19 (i.e., having had a positive test for COVID-19, having had to 
self-isolation, knowing someone who has had COVID-19, knowing someone who has had a 
vaccine or being at an increased risk of COVID-19). Finally, as mistrust and confidence in the 
effectiveness of vaccines has been a reported issue for parents consenting to children receiving 
vaccines, parental mistrust and confidence in children being vaccinated will be included.  
 
Aims of the Study 
1. To assess COVID-19 vaccine uptake and hesitancy in Northern Ireland and the Republic 
of Ireland. 
2. To assess Attitudes, Subjective Norms and Perceived Behavioural Control as predictors 
of intentions to vaccinate against COVID-19. 
3. To consider Demographic factors, Confidence in getting a vaccine and Previous 
experiences of COVID-19 on intention to vaccinate. 
4. To consider confidence in giving the COVID-19 vaccine to children 






Research Design and Recruitment 
Participants were recruited via social media platforms, Twitter and Facebook. Data was 
collected via a Qualtrics cross sectional survey between 29/01/2021 – 23/02/2021 (i.e. seven 
weeks after the first COVID-19 Vaccination, and during a national lockdown in NI and ROI). 
Measures included in the Survey 
Previous Experience of COVID-19 
All participants reported either yes or no to: having had a positive test for COVID-19; are they at 
an increased risk of COVID-19; have they had to self-isolate; did they know someone with 
COVID-19; and did they know someone who had received a COVID-19 vaccination.  
Vaccine Confidence Scale (Gilkey et al., 2014) 
Consists of eight items assessing three factors: benefits of vaccination (Benefits), the harms of 
vaccination (Harms), and trust in health care providers (Trust).  Each item used an 11-point 
response scale ranging from 0 (strongly disagree) to 10 (strongly agree). The scale is valid and 
reliable across many diverse populations (Gilkey et al., 2014: Gilkey et al., 2016).  
Vaccine Attitudes Examination Scale (VAX) (Martin & Petrie, 2017) 
Consists of 12 items assessing four factors (Vaccine Mistrust, future worries, profiteering, and 
preference for natural immunity). Items were presented in the form of statements, with 
responses on a 6-point Likert-type scale ranging from “strongly agree” to “strongly disagree.” 
Higher scores reflect stronger antivaccination attitudes. 
Adapted version of Theory of Planned Behaviour Vaccine Questionnaire (Ajzen, 2013)  Consists 
of 19 items that assess Attitudes, Subjective Norm, Perceived Behavioural Control and 
Intentions to receive a COVID-19 vaccination. Items were presented in a 7-point Likert Scale 
ranging from “strongly disagree” to “strongly agree”. In the absence of a COVID-19 
questionnaire, the original scale was adapted to include the word COVID-19 in items when 
referring to vaccination to make the scale specific to assessment of COVID-19. 
Ethical Approval 
Ethical approval was granted by Ulster University. All participants provided informed consent 
and were free to withdraw at any time. No personal identifying data was collected to ensure 
confidentiality. Participants on completion of the survey were invited to follow a separate online 
weblink to take part in interviews to discuss vaccine hesitancy, the interviews are ongoing and 
will be reported separately. 
Data Handling 
The mean or sum of participants’ responses were calculated as per the scoring criteria for each 
measure. Analysis was conducted using Statistical Package for the Social Sciences 26 
(copyright IBM corp., NY, USA) with the alpha level set to p < .05. Pearson’s correlations were 
considered weak, moderate and strong when r = .20, .50 and .80 respectively. Given the 
sample size was n= 386, central limit theorem inferred the data was normally distributed. 
Levene’s tests confirmed homogeneity of variances for all statistical tests henceforth. Pearson’s 
bivariate correlations were conducted to assess whether relationships existed between TPB 
factors, VAX, VCS. Independent samples t-tests assessed whether there was a significant 
difference in gender or country. Linear Regression analysis was calculated to establish a best fit 
model for predicting vaccine intentions using the Theory of Planned Behaviour Factors 
(Attitudes, Subjective Norms, Perceived Competence, Intentions, gender and previous 





A total of 439 participants took part with 386 (Mean Age = 42.23; SD = 12.16; Range = 19-81; 
83% = female, 17% = male) completing all questions.  
 
53% were from Northern Ireland, 43% Republic of Ireland, 5% from Germany, England, or USA.  
 
The majority of the sample were white 99%, .3% were Hispanic Latino, .3% Black, and .3% 
Mixed Race.  
 
Educational achievement included University Bachelor Degree =7.3%, Master’s Degree = 
13.2%, PhD or higher =11.7%, Trade/school 39.1%, and 28.8% preferred not to say. 
 
Most of the sample were in full time employment =53.4%, employed part time =19.2%, retired 
=9.6%, Unemployed/furloughed as a result of Covid-19 =6.7%, Unemployed seeking 
employment = 5.3%, and 6% preferred not to say. 
 
 




























Table 1: Mean scores, standard deviation, range and possible range for the: Vaccine 
Confidence Scale; Vaccine Attitudes Examination (VAX) Scale; and Theory of Planned 
Behaviour subscales (Attitudes, Subjective Norms, Perceived Behavioural Control and Intention 
to get a vaccine). 
 
There was a high level of confidence (7.98) in getting the COVID-19 vaccine as indicated in the 
VCS scale. There was also a high mean intention score (6.12) to get a COVID-19 vaccine.  
There was a low mean score (2.49) on the VAX scale indicating low vaccine hesitancy in the 
sample. Subjective Norm and PBC scores were high. No gender effects were found for any of 
the scales. The mean scores for the sub factors of the VAX scale include: Worry about 
unforeseen future events as a result of the vaccine was the highest (M=3.32, SD=.82), followed 
by views of natural immunity (M=2.44, SD =.9), pharmaceutical company profiteering (M=2.17, 
SD=.98) and mistrust of vaccine benefit (M=1.97, SD=.89). 
 
A linear multiple regression was calculated to determine what were the predictors of intention to 
vaccinate. Theory of Planned Behaviour factors that predicted Intentions to vaccinate included 
Attitudes, Subjective Norms, and the VAX Mistrust Factor. Other potential factors for vaccine 
uptake as listed on Table 2 did not predict intentions to vaccinate. 
 
Table 2: Linear Regression Model Predicting Vaccine Intentions 
 
 
Participant responses to the individual questions included in the Vaccine Confidence Scale and 




























































• Theory of Planned Behaviour factors predicted intention to vaccinate. In particular, 
attitudes towards COVID-19 vaccines, subjective norms and mistrust are the main 
factors that predict vaccine intention in Northern Ireland and the Republic of Ireland. 
• 66.7% intend to get a vaccination as soon as possible 
• 27.15% will get their vaccine when others get theirs and when it is clear there are no 
side effects. 
• 6.15% of the sample have no intention of getting a vaccine 
• There is a high mean intention (M=6.12) to get a COVID-19 vaccine (TPB) 
• There is a high level of confidence to get a COVID-19 vaccine (VCS) 
• There is a Low vaccine hesitancy (score (M=2.49) as measured by the VAX scale. 




• Encourage positive attitudes towards getting the vaccine.  
• Target hesitant population to change attitudes through targeting subjective norms- 
campaigns that allow people to see and hear about others receiving the vaccine. 
• Reduce mistrust and worry of the side effects of the vaccine 
• There is uncertainty and mistrust of side effects for children, this may because there is 
no vaccine currently available for children, or parents being apprehensive about children 
receiving a safe vaccine in the future. 
• Repeat a shorter version of the survey to monitor changes in attitudes, particularly 
mistrust and worry, be more targeted to parents, and those in the community who are 
likely more hesitant. 
• Qualitative interviews are currently underway to understand those who were identified as 
hesitant. Considering targeting parents, or those in professions that are more likely to be 
hesitant is advised.  
•  
Limitations: 
The study had several limitations that should be considered when interpreting the report. 
• 83% of the sample were female  
• Mean average age was 42 years 
• Survey was completed 29th January- 23rd February, 7 weeks since the first vaccine was 
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